The relationship between nicotinic receptors and cognitive functioning in healthy aging: An in vivo positron emission tomography (PET) study with 2-[ 18F]Fluoro-A-85380

Synapse

Volumn 63, Issue 9, 2009, Pages 752-763

  Ellis, Julia R ^a,b   Nathan, P J ^a,c   Villemagne, V L ^b   Mulligan, R S ^b   Ellis, K A ^d   Tochon Danguy, H J ^b   Chan, J G ^b   O'Keefe, G J ^b   Bradley, J ^b   Savage, G ^a,e   Rowe, C C ^b  

^a MONASH UNIVERSITY   (Australia)

^b AUSTIN HOSPITAL   (Australia)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e MACQUARIE UNIVERSITY   (Australia)

Author keywords

Aging; Cholinergic system; Cognition; Molecular imaging; Nicotinic receptor; PET

Indexed keywords

2 FLUORO 3 (2 AZETIDINYLMETHOXY)PYRIDINE F 18; NICOTINIC RECEPTOR ALPHA4BETA2; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; AGED; AGING; ARTICLE; ATTENTION; BRAIN REGION; COGNITION; CONTROLLED STUDY; DISTRIBUTION VOLUME; DRUG BINDING; EPISODIC MEMORY; FEMALE; HUMAN; HUMAN EXPERIMENT; IN VIVO STUDY; MALE; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENESCENCE; TASK PERFORMANCE;

ACETYLCHOLINE; ADULT; AGED; AGED, 80 AND OVER; AGING; AZETIDINES; BINDING, COMPETITIVE; BRAIN; BRAIN MAPPING; COGNITION DISORDERS; FEMALE; FLUORINE RADIOISOTOPES; HUMANS; MALE; MEMORY DISORDERS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POSITRON-EMISSION TOMOGRAPHY; RECEPTORS, NICOTINIC; YOUNG ADULT;

EID: 68049130974     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20642     Document Type: Article

References (129)

1. Abrahams S, Goldstein LH, Simmons A, Brammer MJ, Williams SC, Giampietro VP, Andrew CM, Leigh PN. 2003. Functional magnetic resonance imaging of verbal fluency and confrontation naming using compressed image acquisition to permit overt responses. Hum Brain Mapp 20:29-40. (Pubitemid 37070141)
2. Amunts K, Weiss PH, Mohlberg H, Pieperhoff P, Eickhoff S, Gurd JM, Marshall JC, Shah NJ, Fink GR, Zilles K. 2004. Analysis of neural mechanisms underlying verbal fluency in cytoarchitectonically defined stereotaxic space - the roles of Brodmann areas 44 and 45. Neuroimage 22:42-56. (Pubitemid 38515812)
3. Arranz B, Eriksson A, Mellerup E, Plenge P, Marcusson J. 1993. Effect of aging in human cortical pre- and postsynaptic serotonin binding sites. Brain Res 620:163-166. (Pubitemid 23225860)
4. Baeken C, D'Haenen H, Flamen P, Mertens J, Terriere D, Chavatte K, Boumon R, Bossuyt A. 1998. 123I-5-I-R91150, a new single-photon emission tomography ligand for 5-HT2A receptors: Influence of age and gender in healthy subjects. Eur J Nucl Med 25:1617-1622. (Pubitemid 29008343)
5. Banken JA. 1985. Clinical utility of considering digit forward and digits backward as separate components of the Wechsler Adult Intelligence Scale-Revised. J Clin Psychol 48:686-691.
6. Bartus RT. 2000. On neurodegenerative diseases, models, and treatment strategies: Lessons learned and lessons forgotten a generation following the cholinergic hypothesis. Exp Neurol 163:495-529.
7. Benedict RH, Schretlen D, Groninger L, Brandt J. 1998. Hopkins Verbal Learning Test-Revised: Normative data and analysis of inter-form and test-retest reliability. Clin Neuropsychol 12:43-55. (Pubitemid 28168220)
8. Benjamini Y, Hochberg Y. 1995. Controlling the False Discovery Rate: A practical and powerful approach to multiple testing. J R Stat Soc 57:289-300.
9. Benton AL. 1968. Differential behavioural effects of frontal lobe disease. Neuropsychologia 6:53-60.
10. Benton AL, Hamsher K. 1976. Multilingual aphasia examination. Iowa City: University of Iowa.
11. Bird TD, Stranahan S, Sumi SM, Raskind M. 1983. Alzheimer's disease: Choline acetyltransferase activity in brain tissue from clinical and pathological subgroups. Ann Neurol 14:284-293.
12. Black FW. 1986. Digit repetition in brain-damaged adults: Clinical and theoretical implications. J Clin Psychol 42:770-782.
13. Blin J, Baron JC, Dubois B, Crouzel C, Fiorelli M, Attar-Levy D, Pillon B, Fournier D, Vidailhet M, Agid Y. 1993. Loss of brain 5-HT2 receptors in Alzheimer's disease. In vivo assessment with positron emission tomography and [18F]setoperone. Brain 116 (Part 3):497-510.
14. Boess FG, De Vry J, Erb C, Flessner T, Hendrix M, Luithle J, Methfessel C, Riedl B, Schnizler K, van der Staay FJ, van Kampen M, Wiese WB, Koenig G. 2007. The novel α7 nicotinic acetylcholine receptor agonist N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-7-[2-(methoxy)phenyl]-1-benzofuran-2- carboxamide improves working and recognition memory in rodents. J Pharmacol Exp Ther 321:716-725. (Pubitemid 46624485)
15. Bopp KL, Verhaeghen P. 2005. Aging and verbal memory span: A meta-analysis. J Gerontol B Psychol Sci Soc Sci 60:P223-P233. (Pubitemid 41242561)
16. Bowen DM, Smith CB, White P, Davison AN. 1976. Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain 99:459-496.
17. Bowen DM, Smith CB, White P, Flack RH, Carrasco LH, Gedye JL, Davison AN. 1977. Chemical pathology of this organic dementias. II. Quantitative estimation of cellular changes in post-mortem brains. Brain 100:427-453.
18. Bowen DM, White P, Spillane JA, Goodhardt MJ, Curzon G, Iwangoff P, Meier-Ruge W, Davison AN. 1979. Accelerated ageing or selective neuronal loss as an important cause of dementia? Lancet 1:11-14.
19. Brandt J, Benedict RH. 2001. Hopkin's Verbal Learning Test-Revised. Professional Manual. Odessa, FL: Psychological Assessment Resources.
20. Buck A, Mulholland GK, Papadopoulos SM, Koeppe RA, Frey KA. 1996. Kinetic evaluation of positron-emitting muscarinic receptor ligands employing direct intracarotid injection. J Cereb Blood Flow Metab 16:1280-1287. (Pubitemid 26365381)
21. Carlsson A, Adolfsson R, Aquilonius SM, Gottfries CG, Oreland L, Svennerholm L, Winblad B. 1980. Biogenic amines in human brain in normal aging, senile dementia, and chronic alcoholism. Adv Biochem Psychopharmacol 23:295-304.
22. Cheetham SC, Crompton MR, Katona CL, Horton RW. 1988. Brain 5-HT2 receptor binding sites in depressed suicide victims. Brain Res 443:272-280. (Pubitemid 18062795)
23. Chefer SI, Horti AG, Lee KS, Koren AO, Jones DW, Gorey JG, Links JM, Mukhin AG, Weinberger DR, London ED. 1998. In vivo imaging of brain nicotinic acetylcholine receptors with 5-[123I]iodo-A-85380 using single photon emission computed tomography. Life Sci 63:PL355-PL360.
24. Collins DL, Neelin P, Peters TM, Evans AC. 1994. Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J Comput Assist Tomogr 18:192-205. (Pubitemid 24100002)
25. Coull JT, Frith CD, Frackowiak RS, Grasby PM. 1996. A fronto-parietal network for rapid visual information processing: A PET study of sustained attention and working memory. Neuropsychologia 34:1085-1095.
26. Court JA, Perry EK, Spurden D, Griffiths M, Kerwin JM, Morris CM, Johnson M, Oakley AE, Birdsall NJ, Clementi F, Perry RH. 1995. The role of the cholinergic system in the development of the human cerebellum. Brain Res Dev Brain Res 90:159-167.
27. Court JA, Lloyd S, Johnson M, Griffiths M, Birdsall NJ, Piggott MA, Oakley AE, Ince PG, Perry EK, Perry RH. 1997. Nicotinic and muscarinic cholinergic receptor binding in the human hippocampal formation during development and aging. Brain Res Dev Brain Res 101:93-105. (Pubitemid 27323804)
28. Court JA, Martin-Ruiz C, Graham A, Perry E. 2000. Nicotinic receptors in human brain: Topography and pathology. J Chem Neuroanat 20:281-298. (Pubitemid 32162887)
29. Daube-Witherspoon MW, Matej S, Karp JS, Lewitt RM. 2001. Application of the 3D row action maximum likelihood algorithm to clinical PET imaging. IEEE Trans Nucl Sci 48:24-30.
30. Davies P, Verth AH. 1977. Regional distribution of muscarinic acetylcholine receptor in normal and Alzheimer's-type dementia brains. Brain Res 138:385-392. (Pubitemid 8233614)
31. Decker MW. 1987. The effects of aging on hippocampal and cortical projections of the forebrain cholinergic system. Brain Res 434:423-438.
32. DeKosky ST, Scheff SW, Markesbery WR. 1985. Laminar organization of cholinergic circuits in human frontal cortex in Alzheimer's disease and aging. Neurology 35:1425-1431.
33. Delbecq-Derouesne J, Beauvois MF. 1989. Memory processes and aging: A defect of automatic rather than controlled processes? Arch Gerontol Geriatr Suppl 1:121-150.
34. Delis DC, Kramer JH, Kaplan E, Ober BA. 2000. California Verbal Learning Test-Second Edition Adult Version. San Antonio, TX: The Psychological Corporation.
35. Deweer B, Lehericy S, Pillon B, Baulac M, Chiras J, Marsault C, Agid Y, Dubois B. 1995. Memory disorders in probable Alzheimer's disease: The role of hippocampal atrophy as shown with MRI. J Neurol Neurosurg Psychiatry 58:590-597.
36. Dewey SL, Volkow ND, Logan J, MacGregor RR, Fowler JS, Schlyer DJ, Bendriem B. 1990. Age-related decreases in muscarinic cholinergic receptor binding in the human brain measured with positron emission tomography (PET). J Neurosci Res 27:569-575.
37. Dickstein DL, Kabaso D, Rocher AB, Luebke JI, Wearne SL, Hof PR. 2007. Changes in the structural complexity of the aged brain. Aging Cell 6:275-284. (Pubitemid 46785133)
38. Dillon KA, Gross-Isseroff R, Israeli M, Biegon A. 1991. Autoradiographic analysis of serotonin 5-HT1A receptor binding in the human brain postmortem: Effects of age and alcohol. Brain Res 554:56-64.
39. Dobbs AR, Rule BG. 1989. Adult age differences in working memory. Psychol Aging 4:500-503.
40. Dolle F, Dolci L, Valette H, Hinnen F, Vaufrey F, Guenther I, Fuseau C, Coulon C, Bottlaender M, Crouzel C. 1999. Synthesis and nicotinic acetylcholine receptor in vivo binding properties of 2-fluoro-3-[2(S)-2-azetidinylmethoxy] pyridine: A new positron emission tomography ligand for nicotinic receptors. J Med Chem 42:2251-2259. (Pubitemid 29284245)
41. Ellis JR, Ellis KA, Bartholomeusz CF, Harrison BJ, Wesnes KA, Erskine FF, Vitetta L, Nathan PJ. 2006. Muscarinic and nicotinic receptors synergistically modulate working memory and attention in humans. Int J Neuropsychopharmacol 9:175-189. (Pubitemid 43255831)
42. 18F]Fluoro-A-85380 PET study. Neurobiol Learn Mem 90:404-412.
43. Fadda P, Martellotta MC, Gessa GL, Fratta W. 1993. Dopamine and opioids interactions in sleep deprivation. Prog Neuropsychopharmacol Biol Psychiatry 17:269-278. (Pubitemid 23024090)
44. Falk L, Nordberg A, Seiger A, Kjaeldgaard A, Hellstrom-Lindahl E. 2003. Higher expression of α7 nicotinic acetylcholine receptors in human fetal compared to adult brain. Brain Res Dev Brain Res 142:151-160. (Pubitemid 36593158)
45. Flynn DD, Mash DC. 1986. Characterization of L-[3H]nicotine binding in human cerebral cortex: Comparison between Alzheimer's disease and the normal. J Neurochem 47:1948-1954.
46. Folstein MF, Folstein SE, McHugh PR. 1975. Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198.
47. Friston KJ, Frith CD, Liddle PF. 1991. Comparing functional (PET) images: The assessment of significant change. J Cereb Blood Flow Metab 11:690-699.
48. Fujita M, Tamagnan G, Zoghbi SS, Al-Tikriti MS, Baldwin RM, Seibyl JP, Innis RB. 2000. Measurement of α4β2 nicotinic acetylcholine receptors with [123I]5-I-A-85380 SPECT. J Nucl Med 41:1552-1560.
49. Fujita M, Seibyl JP, Vaupel DB, Tamagnan G, Early M, Zoghbi SS, Baldwin RM, Horti AG, Kore NA, Mukhin AG, Khan S, Bozkurt A, Kimes AS, London ED, Innis RB. 2002. Whole-body biodistribution, radiation absorbed dose, and brain SPET imaging with [123I]5-I-A-85380 in healthy human subjects. Eur J Nucl Med Mol Imaging 29:183-190. (Pubitemid 34143450)
50. Gallezot JD, Bottlaender M, Gregoire MC, Roumenov D, Deverre JR, Coulon C, Ottaviani M, Dolle F, Syrota A, Valette H. 2005. In vivo imaging of human cerebral nicotinic acetylcholine receptors with 2-18F-fluoro-A-85380 and PET. J Nucl Med 46:240-247.
51. Goodglass H, Kaplan E. 1972. The assessment of aphasisas and related disorders. Philadelphia: Lea and Febiger.
52. Grady CL, Craik FI. 2000. Changes in memory processing with age. Curr Opin Neurobiol 10:224-231.
53. Groth KE, Allen PA. 2000. Visual attention and aging. Front Biosci 5:D284-D297.
54. Hellstrom-Lindahl E, Court JA. 2000. Nicotinic acetylcholine receptors during prenatal development and brain pathology in human aging. Behav Brain Res 113:159-168. (Pubitemid 30645553)
55. Hellstrom-Lindahl E, Winblad B, Nordberg A. 1993. Muscarinic and nicotinic receptor changes in the cortex and thalamus of brains of chronic alcoholics. Brain Res 620:42-48. (Pubitemid 23225842)
56. Horti AG, Villemagne VL. 2006. The quest for Eldorado: Development of radioligands for in vivo imaging of nicotinic acetylcholine receptors in human brain. Curr Pharm Des 12:3877-3900. (Pubitemid 44560700)
57. Horti AG, Scheffel U, Koren AO, Ravert HT, Mathews WB, Musachio JL, Finley PA, London ED, Dannals RF. 1998. 2-[18F]Fluoro-A-85380, an in vivo tracer for the nicotinic acetylcholine receptors. Nucl Med Biol 25:599-603. (Pubitemid 28442724)
58. Horti AG, Koren AO, Lee KS, Mukhin AG, Vaupel DB, Kimes AS, Stratton M, London ED. 1999. Radiosynthesis and preliminary evaluation of 5-[123/125I]iodo-3-(2(S)-azetidinylmethoxy)pyridine: A radioligand for nicotinic acetylcholine receptors. Nucl Med Biol 26:175-182.
59. Horti AG, Chefer SI, Mukhin AG, Koren AO, Gundisch D, Links JM, Kurian V, Dannals RF, London ED. 2000. 6-[18F]fluoro-A-85380, a novel radioligand for in vivo imaging of central nicotinic acetylcholine receptors. Life Sci 67:463-469.
60. HutchisonCW, Nathan PJ, Mrazek L, Stough C. 2001. Cholinergic modulation of speed of early information processing: The effect of donepezil on inspection time. Psychopharmacology (Berl) 155:440-442. (Pubitemid 32523116)
61. Iyo M, Yamasaki T. 1993. The detection of age-related decrease of dopamine D1. D2 and serotonin 5-HT2 receptors in living human brain. Prog Neuropsychopharmacol Biol Psychiatry 17:415-421.
62. Johnson SC, Saykin AJ, Flashman LA, McAllister TW, Sparling MB. 2001. Brain activation on fMRI and verbal memory ability: Functional neuroanatomic correlates of CVLT performance. J Int Neuropsychol Soc 7:55-62.
63. Joy S, Kaplan E, Fein D. 2004. Speed and memory in the WAIS-III Digit Symbol-Coding subtest across the adult lifespan. Arch Clin Neuropsychol 19:759-767. (Pubitemid 39013341)
64. Kimes AS, Horti AG, London ED, Chefer SI, Contoreggi C, Ernst M, Friello P, Koren AO, Kurian V, Matochik JA, Pavlova O, Vaupel DB, Mukhin AG. 2003. 2-[18F]F-A-85380: PET imaging of brain nicotinic acetylcholine receptors and whole body distribution in humans. Faseb J 17:1331-1333.
65. Kuhl DE, Koeppe RA, Minoshima S, Snyder SE, Ficaro EP, Foster NL, Frey KA, Kilbourn MR. 1999. In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease. Neurology 52:691-699.
66. Lacritz LH, Cullum CM. 1998. The Hopkins Verbal Learning Test and CVLT: A preliminary comparison. Arch Clin Neuropsychol 13:623-628.
67. Lacritz LH, Cullum CM, Weiner MF, Rosenberg RN. 2001. Comparison of the Hopkins verbal learning test-revised to the California verbal learning test in Alzheimer's disease. Appl Neuropsychol 8:180-184.
68. Lee KS, Frey KA, Koeppe RA, Buck A, Mulholland GK, Kuhl DE. 1996. In vivo quantification of cerebral muscarinic receptors in normal human aging using positron emission tomography and [11C]tropanyl benzilate. J Cereb Blood Flow Metab 16:303-310.
69. Levin ED, Bettegowda C, Blosser J, Gordon J. 1999. AR-R17779, and α7 nicotinic agonist, improves learning and memory in rats. Behav Pharmacol 10:675-680. (Pubitemid 30026062)
70. Lewin JS, Friedman L, Wu D, Miller DA, Thompson LA, Klein SK, Wise AL, Hedera P, Buckley P, Meltzer H, Friedland RP, Duerk JL. 1996. Cortical localization of human sustained attention: Detection with functional MR using a visual vigilance paradigm. J Comput Assist Tomogr 20:695-701. (Pubitemid 26303741)
71. Lezak MD. 1995. Neuropsychological assessment. New York: Oxford University Press.
72. Light LL. 1991. Memory and aging: Four hypotheses in search of data. Annu Rev Psychol 42:333-376.
73. London ED, Ball MJ, Waller SB. 1989. Nicotinic binding sites in cerebral cortex and hippocampus in Alzheimer's dementia. Neurochem Res 14:745-750. (Pubitemid 19255829)
74. Mackay AV, Davies P, Dewar AJ, Yates CM. 1978. Regional distribution of enzymes associated with neurotransmission by monoamines, acetylcholine and GABA in the human brain. J Neurochem 30:827-839. (Pubitemid 8334179)
75. Mamede M, Ishizu K, Ueda M, Mukai T, Iida Y, Fukuyama H, Saga T, Saji H. 2004. Quantification of human nicotinic acetylcholine receptors with 123I-5IA SPECT. J Nucl Med 45:1458-1470. (Pubitemid 47618499)
76. Marcusson JO, Morgan DG, Winblad B, Finch CE. 1984a. Serotonin-2 binding sites in human frontal cortex and hippocampus. Selective loss of S-2A sites with age. Brain Res 311:51-56.
77. Marcusson J, Oreland L, Winblad B. 1984b. Effect of age on human brain serotonin (S-1) binding sites. J Neurochem 43:1699-1705. (Pubitemid 15212089)
78. Marutle A, Warpman U, Bogdanovic N, Nordberg A. 1998. Regional distribution of subtypes of nicotinic receptors in human brain and effect of aging studied by (+/-)-[3H]epibatidine. Brain Res 801:143-149. (Pubitemid 28401657)
79. Mennemeier MS, Chatterjee A, Watson RT, Wertman E, Carter LP, Heilman KM. 1994. Contributions of the parietal and frontal lobes to sustained attention and habituation. Neuropsychologia 32:703-716. (Pubitemid 24186682)
80. Meyers JE, Meyers KR. 1995. Rey Complex Figure Test and Recognition Trial. Odessa: Psychological Assessment Resources Inc.
81. 18F]F-A-85380 PET. Nucl Med Biol 32:585-591.
82. Mitsis EM, Cosgrove KP, Staley JK, Frohlich EB, Bois F, Tamagnan GD, Estok KM, Seibyl JP, Van Dyck CH. 2007. [123I]5-IA-85380 SPECT imaging of β2-nicotinic acetylcholine receptor availability in the aging human brain. Ann N Y Acad Sci 1097:168-170.
83. Mitsis EM, Cosgrove KP, Staley JK, Bois F, Frohlich EB, Tamagnan GD, Estok KM, Seibyl JP, van Dyck CH. 2008. Age-related decline in nicotinic receptor availability with [(123)I]5-IA-85380 SPECT. Neurobiol Aging; doi: 10.1016/j.neurobiolaging. 2007. 12.008.
84. Mozley PD, Kim HJ, Gur RC, Tatsch K, Muenz LR, McElgin WT, Kung MP, Mu M, Myers AM, Kung HF. 1996. Iodine-123-IPT SPECT imaging of CNS dopamine transporters: Nonlinear effects of normal aging on striatal uptake values. J Nucl Med 37:1965-1970. (Pubitemid 26428363)
85. Musachio JL, Villemagne VL, Scheffel UA, Dannals RF, Dogan AS, Yokoi F, Wong DF. 1999. Synthesis of an I-123 analog of A-85380 and preliminary SPECT imaging of nicotinic receptors in baboon. Nucl Med Biol 26:201-207. (Pubitemid 29125338)
86. Namba H, Iyo M, Shinotoh H, Nagatsuka S, Fukushi K, Irie T. 1998. Preserved acetylcholinesterase activity in aged cerebral cortex. Lancet 351:881-882. (Pubitemid 28121184)
87. Nordberg A, Alafuzoff I, Winblad B. 1992. Nicotinic and muscarinic subtypes in the human brain: Changes with aging and dementia. J Neurosci Res 31:103-111.
88. O'Brien JT, Colloby SJ, Pakrasi S, Perry EK, Pimlott SL, Wyper DJ, McKeith IG, Williams ED. 2007. α4β2 Nicotinic receptor status in Alzheimer's disease using 123I-5IA-85380 single-photon-emission computed tomography. J Neurol Neurosurg Psychiatry 78:356-362.
89. Pantel J, Schonknecht P, Essig M, Schroder J. 2004. Distribution of cerebral atrophy assessed by magnetic resonance imaging reflects patterns of neuropsychological deficits in Alzheimer's dementia. Neurosci Lett 361:17-20. (Pubitemid 38609205)
90. Parasuraman R, Giambra L. 1991. Skill development in vigilance: Effects of event rate and age. Psychol Aging 6:155-169.
91. Pardo JV, Fox PT, Raichle ME. 1991. Localization of a human system for sustained attention by positron emission tomography. Nature 349:61-64. (Pubitemid 21912013)
92. Perry EK. 1980. The cholinergic system in old age and Alzheimer's disease. Age Ageing 9:1-8. (Pubitemid 10215539)
93. Perry EK, Perry RH, Smith CJ, Dick DJ, Candy JM, Edwardson JA, Fairbairn A, Blessed G. 1987. Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases. J Neurol Neurosurg Psychiatry 50:806-809. (Pubitemid 17076302)
94. Perry EK, Johnson M, Kerwin JM, Piggott MA, Court JA, Shaw PJ, Ince PG, Brown A, Perry RH. 1992. Convergent cholinergic activities in aging and Alzheimer's disease. Neurobiol Aging 13:393-400.
95. Perry EK, Morris CM, Court JA, Cheng A, Fairbairn AF, McKeith IG, Irving D, Brown A, Perry RH. 1995. Alteration in nicotine binding sites in Parkinson's disease. Lewy body dementia and Alzheimer's disease: Possible index of early neuropathology. Neuroscience 64:385-395.
96. Petersen RC, Smith G, Kokmen E, Ivnik RJ, Tangalos EG. 1992. Memory function in normal aging. Neurology 42:396-401.
97. Phelps EA, Hyder F, Blamire AM, Shulman RG. 1997. FMRI of the prefrontal cortex during overt verbal fluency. Neuroreport 8:561-565. (Pubitemid 27180121)
98. Rinne JO, Lonnberg P, Marjamaki P. 1990. Age-dependent decline in human brain dopamine D1 and D2 receptors. Brain Res 508:349-352.
99. Rinne JO, Myllykyla T, Lonnberg P, Marjamaki P. 1991. A postmortem study of brain nicotinic receptors in Parkinson's and Alzheimer's disease. Brain Res 547:167-170.
100. Rodriguez-Aranda C, Martinussen M. 2006. Age-related differences in performance of phonemic verbal fluency measured by Controlled Oral Word Association Task (COWAT): A meta-analytic study. Dev Neuropsychol 30:697-717. (Pubitemid 44619823)
101. Rosen WG. 1980. Verbal fluency in aging and dementia. J Clin Neuropsychol 2:135-146.
102. Rossor MN, Garrett NJ, Johnson AL, Mountjoy CQ, Roth M, Iversen LL. 1982. A post-mortem study of the cholinergic and GABA systems in senile dementia. Brain 105 (Part 2):313-330.
103. Sarter M, Turchi J. 2002. Age- and dementia-associated impairments in divided attention: Psychological constructs, animal models, and underlying neuronal mechanisms. Dement Geriatr Cogn Disord 13:46-58. (Pubitemid 33153188)
104. Saxton J, Ratcliff G, Munro CA, Coffey EC, Becker JT, Fried L, Kuller L. 2000. Normative data on the Boston Naming Test and two equivalent 30-item short forms. Clin Neuropsychol 14:526-534.
105. Saykin AJ, Johnson SC, Flashman LA, McAllister TW, Sparling M, Darcey TM, Moritz CH, Guerin SJ, Weaver J, Mamourian A. 1999. Functional differentiation of medial temporal and frontal regions involved in processing novel and familiar words: An fMRI study. Brain 122 (Part 10):1963-1971. (Pubitemid 29473867)
106. Seidenberg M, Geary E, Hermann B. 2005. Investigating temporal lobe contribution to confrontation naming using MRI quantitative volumetrics. J Int Neuropsychol Soc 11:358-366. (Pubitemid 41167172)
107. Shih JC, Young H. 1978. The alteration of serotonin binding sites in aged human brain. Life Sci 23:1441-1448. (Pubitemid 9095793)
108. Sihver W, Gillberg PG, Svensson AL, Nordberg A. 1999. Autoradiographic comparison of [3H](2)nicotine, [3H]cytisine and [3H]epibatidine binding in relation to vesicular acetylcholine transport sites in the temporal cortex in Alzheimer's disease. Neuroscience 94:685-696. (Pubitemid 29474957)
109. Sparks DL. 1989. Aging and Alzheimer's disease. Altered cortical serotonergic binding. Arch Neurol 46:138-140.
110. Spitzer RL, Williams JB, Kroenke K, Linzer M, deGruy FV III, Hahn SR, Brody D, Johnson JG. 1994. Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA 272:1749-1756.
111. Spokes EG. 1979. An analysis of factors influencing measurements of dopamine, noradrenaline, glutamate decarboxylase and choline acetylase in human post-mortem brain tissue. Brain 102:333-346.
112. Spreen O, Strauss E. 1991. A compendium of neuropsychological tests: Administration, norms and commentary. New York: Oxford University Press.
113. Spreen O, Strauss E. 1998. A compendium of neuropsychological tests. New York: Oxford University Press.
114. Sun W, Ginovart N, Ko F, Seeman P, Kapur S. 2003. In vivo evidence for dopamine-mediated internalization of D2-receptors after amphetamine: Differential findings with [3H]raclopride versus [3H]spiperone. Mol Pharmacol 63:456-462.
115. Thompson JC, Stough C, Ames D, Ritchie C, Nathan PJ. 2000. Effects of the nicotinic antagonist mecamylamine on inspection time. Psychopharmacology (Berl) 150:117-119. (Pubitemid 30350821)
116. Tsukiura T, Fujii T, Takahashi T, Xiao R, Inase M, Iijima T, Yamadori A, Okuda J. 2001. Neuroanatomical discrimination between manipulating and maintaining processes involved in verbal working memory; a functional MRI study. Brain Res Cogn Brain Res 11:13-21. (Pubitemid 32182400)
117. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, Mazoyer B, Joliot M. 2002. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 15:273-289. (Pubitemid 34852226)
118. Ueda M, Iida Y, Mukai T, Mamede M, Ishizu K, Ogawa M, Magata Y, Konishi J, Saji H. 2004. 5-[123I]Iodo-A-85380: Assessment of pharmacological safety, radiation dosimetry and SPECT imaging of brain nicotinic receptors in healthy human subjects. Ann Nucl Med 18:337-344. (Pubitemid 39100102)
119. Valette H, Bottlaender M, Dolle F, Guenther I, Fuseau C, Coulon C, Ottaviani M, Crouzel C. 1999. Imaging central nicotinic acetylcholine receptors in baboons with [18F]fluoro-A-85380. J Nucl Med 40:1374-1380. (Pubitemid 29385648)
120. van Dyck CH, Seibyl JP, Malison RT, Laruelle M, Wallace E, Zoghbi SS, Zea-Ponce Y, Baldwin RM, Charney DS, Hoffer PB. 1995. Age-related decline in striatal dopamine transporter binding with iodine-123-β-CITSPECT. J Nucl Med 36:1175-1181.
121. Van Kampen M, Selbach K, Schneider R, Schiegel E, Boess F, Schreiber R. 2004. AR-R 17779 improves social recognition in rats by activation of nicotinic α7 receptors. Psychopharmacology (Berl) 172:375-383. (Pubitemid 38650972)
122. Warpman U, Nordberg A. 1995. Epibatidine and ABT 418 reveal selective losses of α4β2 nicotinic receptors in Alzheimer brains. Neuroreport 6:2419-2423. (Pubitemid 26010081)
123. Wechsler D. 1997. WAIS-III administration and scoring manual. San Antonio, TX: Psychological Corporation.
124. White P, Hiley CR, Goodhardt MJ, Carrasco LH, Keet JP, Williams IE, Bowen DM. 1977. Neocortical cholinergic neurons in elderly people. Lancet 1:668-671. (Pubitemid 8121566)
125. Wielgos CM, Cunningham WR. 1999. Age-related slowing on the Digit Symbol task: Longitudinal and cross-sectional analyses. Exp Aging Res 25:109-120.
126. Wiggs CL, Weisberg J, Martin A. 1999. Neural correlates of semantic and episodic memory retrieval. Neuropsychologia 37:103-118. (Pubitemid 28555766)
127. Wong DF, Wagner HN Jr, Dannals RF, Links JM, Frost JJ, Ravert HT, Wilson AA, Rosenbaum AE, Gjedde A, Douglass KH, Petronis JD, Folstein MF, Toung JK, Burns D, Kuhar MJ. 1984. Effects of age on dopamine and serotonin receptors measured by positron tomography in the living human brain. Science 226:1393-1396.
128. Young JW, Finlayson K, Spratt C, Marston HM, Crawford N, Kelly JS, Sharkey J. 2004. Nicotine improves sustained attention in mice: Evidence for involvement of the α7 nicotinic acetylcholine receptor. Neuropsychopharmacology 29:891-900. (Pubitemid 38526789)
129. Zigmond AS, Snaith RP. 1983. The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361-370.